DeepEcho receives US FDA 510(k) clearance for its AI-powered prenatal imaging: New York Wednesday, June 25, 2025, 12:00 Hrs [IST] DeepEcho, an AI first healthtech company revoluti ...

NEW YORK, NY AND RABAT, MOROCCO / ACCESS Newswire / June 20, 2025 / DeepEcho, an AI first healthtech company revolutionizing maternal and fetal health, has received clearance from the U.S. Food and ...

Then, under the influence of testosterone, the testes begin to move down into the fetal scrotum. By 32 weeks, both testes ...

Texas Children's Hospital North Austin Campus performs surgery to remove baby's lung mass during birth while still attached ...

Diabetes during pregnancy—whether pre-existing or gestational—may lead to increased fat accumulation around the fetal heart, according to a new meta-analysis published in Biomolecules and Biomedicine.

In a remarkable medical achievement, a senior doctor has successfully performed a radiation-free Endoscopic Retrograde ...

Tech Insights titled “Global Healthcare Management Service Organization Market Size & Trends Report (2025-2030)”, the global ...

This study highlights the potential of heart rate variability as an early indicator of gestational diabetes, facilitating ...

The article details how Dr. Byrne recognized the value of ultrasound in OB/GYN care well before it became common practice in the United States. During his early medical training, he traveled to ...

Deepecho Inc. received the U.S. FDA’s nod for its AI-based platform that assesses fetal biometry and amniotic fluid volume to improve the efficiency and precision of fetal ultrasound diagnostics.

balloon and blue confetti in the air. @deenajlee "We couldn't help but wonder how [the] blood test results [could] contradict what the ultrasound technician observed," Deena told Newsweek.